In one paragraphArticle in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Isabella Morais Tavares HuberDepartment of Graduate Studies Coordination Office (COPG), Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.ORCID 0000-0001-9536-8542 Emerson Luiz Botelho LourençoPhD Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.ORCID 0000-0002-1798-7871 Salviano Tramontin BellettiniPhD Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.ORCID 0000-0002-0600-5836 Guilherme DonadelPhD Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.
João Francisco Velasquez MatumotoUndergraduate Program in Pharmacy, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.
Sandra Marisa PellosoPhD Program in Health Sciences, Universidade Estadual de Maringá (UEM), Maringá 87020-900, Paraná, Brazil.
Maria Dalva de Barros CarvalhoPhD Program in Health Sciences, Universidade Estadual de Maringá (UEM), Maringá 87020-900, Paraná, Brazil.
Stéfane Lele RossoniPhD Program in Health Sciences, Universidade Estadual de Maringá (UEM), Maringá 87020-900, Paraná, Brazil.ORCID 0009-0005-1906-1203 Mariana Morais Tavares ColferaiDepartment of Dermatology, Municipal Health Authority of Apucarana, Apucarana 86800-260, Paraná, Brazil.
Diego Ricardo ColferaiDepartment of Dermatology, Municipal Health Authority of Apucarana, Apucarana 86800-260, Paraná, Brazil.
Roberto Kenji Nakamura CumanPhD Program in Health Sciences, Universidade Estadual de Maringá (UEM), Maringá 87020-900, Paraná, Brazil.ORCID 0000-0002-4906-887X Leonardo Garcia VelasquezPhD Program in Phytotherapy and Medicinal Plants in Primary Health Care, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
(1) Background: Chemotherapy-induced hematological toxicity remains a major limitation to treatment continuity. Docetaxel is widely used in solid tumors due to its clinical efficacy, despite cumulative bone marrow suppression and splenic alterations.
Indexed as
chemotherapyCurcuma longacytoprotectionhematological parametersspleen-associated hematopoiesis
Identifiers
PMID41677717
PMCPMC12897220
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390